NephroGenex's IPO

NephroGenex raised a round of funding on February 11, 2014. Investors include Public.

NephroGenex is a pharmaceutical company focused on the development of therapeutics to treat kidney disease, an area of significant unmet medical need. Since inception, the company has collaborated wit…

Articles about NephroGenex's IPO: